Skip to main content
Signal8
Haring-Layton MarDee profile photo

MarDee Haring-Layton

CIK: 0001535596

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Dare Bioscience, Inc. logo
DARE

Dare Bioscience, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Dare Bioscience, Inc. logo
    DARE

    Dare Bioscience, Inc.

    Jan 30, 2026
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    49K shares-
  • Dare Bioscience, Inc. logo
    DARE

    Dare Bioscience, Inc.

    Sep 4, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    57K shares-
  • Dare Bioscience, Inc. logo
    DARE

    Dare Bioscience, Inc.

    Jan 28, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    38K shares-

1-3 of 3

About Haring-Layton MarDee

Haring-Layton MarDee (SEC CIK 0001535596) files insider reports with the SEC as Chief Accounting Officer of Dare Bioscience, Inc. (DARE).

Signal8 holds 3 ownership filings by Haring-Layton MarDee, all Form 4s, filed between Jan 31, 2025 and Feb 2, 2026. Those filings report 3 transactions, from Jan 28, 2025 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Haring-Layton MarDee's filings is in SAN DIEGO, CA.

Recent filings by Haring-Layton MarDee

  • Jan 30, 2026: Grant or award of DARE derivative securities (Form 4, code A).
  • Sep 4, 2025: Grant or award of DARE derivative securities (Form 4, code A).
  • Jan 28, 2025: Grant or award of DARE derivative securities (Form 4, code A).

Other insiders filing for Dare Bioscience, Inc. (DARE)

How to read Form 4 transaction codes